Improving treatments for stomach cancer
About David Cunningham
Professor David Cunningham and his team at the Royal Marsden Hospital carry out clinical trials to test new treatments for stomach cancer. They are currently testing a new anti-cancer drug that works by blocking the growth of new blood vessels, a process called angiogenesis.
All cancers need an adequate blood supply to receive essential nutrients and oxygen. Drugs that target angiogenesis may therefore be used alongside existing chemotherapy to successfully treat many different types of cancer in the future.
Other research projects by David Cunningham
CRUK/06/025: ST03: A randomised phase II/III study of peri-operative chemotherapy with or without bevacizumab in patients with operable adenocarcinoma of the stomach and gastro-oesophageal junction
Funding period: 01 December 2006 to 30 November 2013
Site of relapse after chemotherapy atone for stage I and II Hodgkin's disease
Radiother Oncol.2006;78 :1-5